Iranian Journal of Pediatrics

Published by: Kowsar
Crossmark

A Study of Intracoronary Injection of Hematopoietic Stem Cells in Pediatric Dilated Cardiomyopathy: Is It an Applicable Solution for Critically Ill Patients?

Hamid Amoozgar 1 , Mohammad R. Edraki 1 , Maryam Ayatollahi 2 , Mohammad Borzouee 1 , Gholamhossein Ajami 1 , Hamid Mohammadi 1 , * , Nima Mehdizadegan 1 , Nader Shakibazad 3 , Hamid Arabi 1 , Fatehi Alwesabi 1 , Amir Naghshzan 1 and Kambiz Keshavarz 1
Authors Information
1 Neonatology and Cardiac Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Transplant Research Center of Shiraz University of Medical Sciences, Shiraz, Iran
3 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Iranian Journal of Pediatrics: 29 (3); e83408
  • Published Online: May 5, 2019
  • Article Type: Research Article
  • Received: August 17, 2018
  • Revised: December 26, 2018
  • Accepted: January 9, 2019
  • DOI: 10.5812/ijp.83408

To Cite: Amoozgar H, Edraki M R, Ayatollahi M, Borzouee M, Ajami G, et al. A Study of Intracoronary Injection of Hematopoietic Stem Cells in Pediatric Dilated Cardiomyopathy: Is It an Applicable Solution for Critically Ill Patients?, Iran J Pediatr. Online ahead of Print ; 29(3):e83408. doi: 10.5812/ijp.83408.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Theiss HD, David R, Engelmann MG, Barth A, Schotten K, Naebauer M, et al. Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur Heart J. 2007;28(10):1258-64. doi: 10.1093/eurheartj/ehm011. [PubMed: 17395679].
  • 2. Bergmane I, Lacis A, Lubaua I, Jakobsons E, Erglis A. Follow-up of the patients after stem cell transplantation for pediatric dilated cardiomyopathy. Pediatr Transplant. 2013;17(3):266-70. doi: 10.1111/petr.12055. [PubMed: 23458132].
  • 3. Almond CSD, Thiagarajan RR, Piercey GE, Gauvreau K, Blume ED, Bastardi HJ, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009;119(5):717-27. doi: 10.1161/CIRCULATIONAHA.108.815712. [PubMed: 19171850]. [PubMed Central: PMC4278666].
  • 4. Mozid AM, Arnous S, Sammut EC, Mathur A. Stem cell therapy for heart diseases. Br Med Bull. 2011;98:143-59. doi: 10.1093/bmb/ldr014. [PubMed: 21596713].
  • 5. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, et al. Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Arch Intern Med. 2007;167(10):989-97. doi: 10.1001/archinte.167.10.989. [PubMed: 17533201].
  • 6. Janssens SP. Mesenchymal cell therapy for dilated cardiomyopathy: Time to test the water. J Am Coll Cardiol. 2017;69(5):538-40. doi: 10.1016/j.jacc.2016.11.044. [PubMed: 28153109].
  • 7. Seth S, Narang R, Bhargava B, Ray R, Mohanty S, Gulati G, et al. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: Clinical and histopathological results: The first-in-man ABCD (autologous bone marrow cells in dilated cardiomyopathy) trial. J Am Coll Cardiol. 2006;48(11):2350-1. doi: 10.1016/j.jacc.2006.07.057. [PubMed: 17161269].
  • 8. Vrtovec B, Poglajen G, Lezaic L, Sever M, Domanovic D, Cernelc P, et al. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res. 2013;112(1):165-73. doi: 10.1161/CIRCRESAHA.112.276519. [PubMed: 23065358].
  • 9. Zeinaloo A, Zanjani KS, Bagheri MM, Mohyeddin-Bonab M, Monajemzadeh M, Arjmandnia MH. Intracoronary administration of autologous mesenchymal stem cells in a critically ill patient with dilated cardiomyopathy. Pediatr Transplant. 2011;15(8):E183-6. doi: 10.1111/j.1399-3046.2010.01366.x. [PubMed: 20880092].
  • 10. Ng PY, Sin WC, Ng AK, Chan WM. Speckle tracking echocardiography in patients with septic shock: A case control study (SPECKSS). Crit Care. 2016;20(1):145. doi: 10.1186/s13054-016-1327-0. [PubMed: 27177587]. [PubMed Central: PMC4867983].
  • 11. Rupp S, Jux C, Bonig H, Bauer J, Tonn T, Seifried E, et al. Intracoronary bone marrow cell application for terminal heart failure in children. Cardiol Young. 2012;22(5):558-63. doi: 10.1017/S1047951112000066. [PubMed: 22329889].
  • 12. Ayatollahi M, Soleimani M, Geramizadeh B, Imanieh MH. Insulin-like growth factor 1 (IGF-I) improves hepatic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Biol Int. 2011;35(11):1169-76. doi: 10.1042/CBI20110016. [PubMed: 21910691].
  • 13. Ayatollahi M, Geramizadeh B, Zakerinia M, Ramzi M, Yaghobi R, Hadadi P, et al. Human bone marrow-derived mesenchymal stem cell: A source for cell-based therapy. Int J Organ Transplant Med. 2012;3(1):32-41. [PubMed: 25013621]. [PubMed Central: PMC4089277].
  • 14. Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial. JAMA. 2011;306(19):2110-9. doi: 10.1001/jama.2011.1670. [PubMed: 22084195]. [PubMed Central: PMC3600981].
  • 15. Hao M, Wang R, Wang W. Cell therapies in cardiomyopathy: Current status of clinical trials. Anal Cell Pathol (Amst). 2017;2017:9404057. doi: 10.1155/2017/9404057. [PubMed: 28194324]. [PubMed Central: PMC5282433 holders of Cellular Biomedicine Group (NASDAQ: CBMG)].
  • 16. Beitnes JO, Gjesdal O, Lunde K, Solheim S, Edvardsen T, Arnesen H, et al. Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: A 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study. Eur J Echocardiogr. 2011;12(2):98-106. doi: 10.1093/ejechocard/jeq116. [PubMed: 20851818].
  • 17. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Clarke MJ, et al. Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: Factors that may influence outcomes. PLoS One. 2012;7(5). e37373. doi: 10.1371/journal.pone.0037373. [PubMed: 22655042]. [PubMed Central: PMC3360027].
  • 18. Nasseri BA, Kukucka M, Dandel M, Knosalla C, Choi YH, Ebell W, et al. Two-dimensional speckle tracking strain analysis for efficacy assessment of myocardial cell therapy. Cell Transplant. 2009;18(3):361-70. doi: 10.3727/096368909788534924. [PubMed: 19558784].
  • 19. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428(6983):664-8. doi: 10.1038/nature02446. [PubMed: 15034593].
  • 20. Steinhoff G, Nesteruk J, Wolfien M, Grosse J, Ruch U, Vasudevan P, et al. Stem cells and heart disease - Brake or accelerator? Adv Drug Deliv Rev. 2017;120:2-24. doi: 10.1016/j.addr.2017.10.007. [PubMed: 29054357].
  • 21. Traverse JH. Is there a role for intravenous stem cell delivery in nonischemic cardiomyopathy? Circ Res. 2017;120(2):256-8. doi: 10.1161/CIRCRESAHA.116.310342. [PubMed: 28104762]. [PubMed Central: PMC5260805].
  • 22. Cambria E, Pasqualini FS, Wolint P, Gunter J, Steiger J, Bopp A, et al. Translational cardiac stem cell therapy: Advancing from first-generation to next-generation cell types. NPJ Regen Med. 2017;2:17. doi: 10.1038/s41536-017-0024-1. [PubMed: 29302353]. [PubMed Central: PMC5677990].
  • 23. Lezaic L, Haddad F, Vrtovec B, Wu JC. Imaging cardiac stem cell transplantation using radionuclide labeling techniques: Clinical applications and future directions. Methodist Debakey Cardiovasc J. 2013;9(4):218-22. [PubMed: 24298314]. [PubMed Central: PMC3846077].
  • 24. Lacis A. Management of idiopathic dilated cardiomyopathy with intramyocardial stem cell transplantation in children: A retrospective study of 7 patients. Sci J Clin Med. 2013;2(4):129. doi: 10.11648/j.sjcm.20130204.12.
  • 25. Vrtovec B, Poglajen G, Lezaic L, Sever M, Socan A, Domanovic D, et al. Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy. Circulation. 2013;128(11 Suppl 1):S42-9. doi: 10.1161/CIRCULATIONAHA.112.000230. [PubMed: 24030420].
  • 26. Selem SM, Kaushal S, Hare JM. Stem cell therapy for pediatric dilated cardiomyopathy. Curr Cardiol Rep. 2013;15(6):369. doi: 10.1007/s11886-013-0369-z. [PubMed: 23666883]. [PubMed Central: PMC4128369].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments